Ottawa, December 10, 2015: The Canadian Cancer Survivor Network is pleased to announce the launch of its newest website portal on cervical cancer. Approximately 1,050 Canadian women are diagnosed with cervical cancer annually, and this number increases every year. For those dealing with this type of cancer, the journey from diagnosis to treatment and management of the disease is rarely a road travelled alone. Spouses,
Year: 2015
Increased melanoma diagnoses basis for new Melanoma Portal
Ottawa, November 3, 2015: The Canadian Cancer Survivor Network is pleased to announce the launch of its newest website portal on melanoma at https://survivornet.ca/en/cancer_basics/melanoma_portal. Approximately 6,500 Canadians are diagnosed with melanoma annually, and this number increases every year. For those dealing with this type of cancer, the journey from diagnosis to treatment and management of the disease is rarely a road travelled alone. Spouses, partners,
October 13th is Metastatic Breast Cancer Awareness Day!
This October 13th, during breast cancer awareness month, CCSN recognizes the unique experience of metastatic breast cancer patients. Approximately 30 percent of women and men diagnosed with breast cancer will at some point be diagnosed with metastatic breast cancer, and while metastatic breast cancer can be treated, it currently cannot be cured. This does not mean that those living with metastatic breast cancer cannot enjoy
Ottawa Mayor Jim Watson proclaims National Cancer Survivors Day
This morning, Ottawa Mayor Jim Watson proclaimed National Cancer Survivors Day in recognition of the nearly one million cancer survivors living in Canada today. This annual celebration of life took place at City Hall in the presence of representatives of the Canadian Cancer Survivor Network and Prostate Cancer Canada Network Ottawa. On National Cancer Survivors Day and the days following, thousands of cancer survivors and
Take part in CCSN’s important survey on Xgeva!
The purpose of this survey is to provide the Canadian Cancer Survivor Network (CCSN) with insights and perspectives about the use of denosumab (Xgeva) for the prevention of skeletal-related events due to bone metastases from solid tumours. The information gathered from this survey will be used in order to prepare a patient evidence submission to the CADTH Common Drug Review. Please note that your personal
A New Patient Assistance Program For Medical Cannabis Use in Canada
One of our partners, CannTrust, a licensed producer and distributor of medical cannabis in Canada, has introduced a comprehensive patient assistance program for medical cannabis compassionate use in Canada. Known as the CannTrust Accessprogram, it’s available immediately to eligible Canadians whose health plans do not reimburse medical cannabis. Qualified patients will be eligible for up to 30 grams of medical marijuana per month. Three levels